Secukinumab efficacy in patients with PsA is not dependent on patients' body mass index

Ann Rheum Dis. 2022 Mar;81(3):e42. doi: 10.1136/annrheumdis-2020-217251. Epub 2020 Mar 13.
No abstract available

Keywords: DMARDs (biologic); psoriatic arthritis; treatment.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Arthritis, Psoriatic*
  • Body Mass Index
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • secukinumab